chrX-108736275-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001379150.1(IRS4):c.70G>A(p.Ala24Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000752 in 1,197,111 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000027 ( 0 hom., 1 hem., cov: 21)
Exomes 𝑓: 0.0000055 ( 0 hom. 2 hem. )
Consequence
IRS4
NM_001379150.1 missense
NM_001379150.1 missense
Scores
1
4
12
Clinical Significance
Conservation
PhyloP100: 1.59
Genes affected
IRS4 (HGNC:6128): (insulin receptor substrate 4) IRS4 encodes the insulin receptor substrate 4, a cytoplasmic protein that contains many potential tyrosine and serine/threonine phosphorylation sites. Tyrosine-phosphorylated IRS4 protein has been shown to associate with cytoplasmic signalling molecules that contain SH2 domains. The IRS4 protein is phosphorylated by the insulin receptor tyrosine kinase upon receptor stimulation.. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.23424852).
BS2
High Hemizygotes in GnomAdExome4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
IRS4 | NM_001379150.1 | c.70G>A | p.Ala24Thr | missense_variant | 1/2 | ENST00000372129.4 | |
IRS4 | NM_003604.2 | c.70G>A | p.Ala24Thr | missense_variant | 1/1 | ||
IRS4 | XM_011531061.2 | c.70G>A | p.Ala24Thr | missense_variant | 1/3 | ||
IRS4 | XM_006724713.4 | c.70G>A | p.Ala24Thr | missense_variant | 1/2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
IRS4 | ENST00000372129.4 | c.70G>A | p.Ala24Thr | missense_variant | 1/2 | NM_001379150.1 | A2 | ||
IRS4-AS1 | ENST00000668534.1 | n.185C>T | non_coding_transcript_exon_variant | 1/3 | |||||
IRS4 | ENST00000564206.2 | c.70G>A | p.Ala24Thr | missense_variant | 1/1 | P5 | |||
IRS4-AS1 | ENST00000608811.1 | n.265C>T | non_coding_transcript_exon_variant | 1/2 | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000270 AC: 3AN: 110930Hom.: 0 Cov.: 21 AF XY: 0.0000301 AC XY: 1AN XY: 33226
GnomAD3 genomes
AF:
AC:
3
AN:
110930
Hom.:
Cov.:
21
AF XY:
AC XY:
1
AN XY:
33226
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000552 AC: 6AN: 1086181Hom.: 0 Cov.: 33 AF XY: 0.00000563 AC XY: 2AN XY: 355441
GnomAD4 exome
AF:
AC:
6
AN:
1086181
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
355441
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000270 AC: 3AN: 110930Hom.: 0 Cov.: 21 AF XY: 0.0000301 AC XY: 1AN XY: 33226
GnomAD4 genome
AF:
AC:
3
AN:
110930
Hom.:
Cov.:
21
AF XY:
AC XY:
1
AN XY:
33226
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 29, 2022 | The c.70G>A (p.A24T) alteration is located in exon 1 (coding exon 1) of the IRS4 gene. This alteration results from a G to A substitution at nucleotide position 70, causing the alanine (A) at amino acid position 24 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
FATHMM_MKL
Benign
D
LIST_S2
Benign
T
M_CAP
Pathogenic
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
MutationTaster
Benign
N
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Uncertain
D
Sift4G
Uncertain
D
Polyphen
B
Vest4
MutPred
Gain of phosphorylation at A24 (P = 0.0783);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at